BRIEF-Feelgood Svenska signs deal with five municipalities

* Signs deal with five municipalities within Stockholm area: Nacka, Lidingö, Värmdö, Järfälla and Vaxholm

7:55am BST

BRIEF-Neurovive to present topline result of CicloMulsion phase III study in Q2

* Topline result of phase III study of CicloMulsion in acute myocardial infarction expected this quarter

7:41am BST

BRIEF-Faes Farma says bilastine is ready for registration process in Japan

* Says bilastine successfully completed two clinical pivotal studies of phase III in Japan

7:39am BST

BRIEF-SciBase receives US patent approval for its electrodes with micro-needles

* SciBase, a Swedish medtech company that develops and markets a new method for early detection of malignant melanoma, has received approval from the United States Patent and trademark Office (USPTO) regarding its patent application for its electrodes with micro-needles

7:34am BST

BRIEF-Biotie announces agreement with FDA on Special Protocol Assessment

* Says has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 study of tozadenant in Parkinson's disease(PD)

7:15am BST
GlaxoSmithKline PLC 1,464.50p +0.96%
AstraZeneca PLC 4,473.50p +1.10%
Smith & Nephew PLC 1,134.00p -0.53%


  • Sectors
  • Europe
  • U.S.
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.